Host–pathogen interactions in urinary tract infection (original) (raw)

• Foxman, B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis. Mon. 49, 53–70 (2003).
  Article PubMed Google Scholar
• Guay, D. R. Contemporary management of uncomplicated urinary tract infections. Drugs 68, 1169–1205 (2008).
  Article CAS PubMed Google Scholar
• O'Hanley, P. in Urinary Tract Infections: Molecular Pathogenesis and Clinical Management (eds Mobley, H. L. T. & Warren, J. W.) 405–425 (ASM Press, Washington, DC, 1996).
  Google Scholar
• Zorc, J. J., Kiddoo, D. A. & Shaw, K. N. Diagnosis and management of pediatric urinary tract infections. Clin. Microbiol. Rev. 18, 417–422 (2005).
  Article PubMed PubMed Central Google Scholar
• Litwin, M. S. & Saigal, C. S. (Eds) Urologic Diseases in America (Government Printing Office, Washington, D. C., 2007).
  Google Scholar
• DeFrances, C. J., Lucas, C. A., Buie, V. C. & Golosinskiy, A. 2006 National Hospital Discharge Survey. National health statistics reports; no 5. (Hyattsville, MD, 2008).
  Google Scholar
• Hooton, T. M. et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin. Infect. Dis. 50, 625–663 (2010).
  Article PubMed Google Scholar
• Nicolle, L. E. Catheter-related urinary tract infection. Drugs Aging 22, 627–639 (2005).
  Article PubMed Google Scholar
• Mobley, H. L., Donnenberg, M. S. & Hagan, E. C. EcoSal—Escherichia coli and Salmonella: Cellular and Molecular Biology (eds Böck, A. et al.) (ASM Press, Washington, DC, 2009).
  Google Scholar
• Sosa, V., Schlapp, G. & Zunino, P. Proteus mirabilis isolates of different origins do not show correlation with virulence attributes and can colonize the urinary tract of mice. Microbiology 152, 2149–2157 (2006).
  Article CAS PubMed Google Scholar
• Welch, R. A. et al. Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. Proc. Natl Acad. Sci. USA 99, 17020–17024 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Brzuszkiewicz, E. et al. How to become a uropathogen: comparative genomic analysis of extraintestinal pathogenic Escherichia coli strains. Proc. Natl Acad. Sci. USA 103, 12879–12884 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Chen, S. L. et al. Identification of genes subject to positive selection in uropathogenic strains of Escherichia coli: a comparative genomics approach. Proc. Natl Acad. Sci. USA 103, 5977–5982 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Touchon, M. et al. Organised genome dynamics in the Escherichia coli species results in highly diverse adaptive paths. PLoS Genet. 5, e1000344 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Pearson, M. M. et al. The complete genome sequence of uropathogenic Proteus mirabilis, a master of both adherence and motility. J. Bacteriol. 190, 4027–4037 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Sabate, M., Moreno, E., Perez, T., Andreu, A. & Prats, G. Pathogenicity island markers in commensal and uropathogenic Escherichia coli isolates. Clin. Microbiol. Infect. 12, 880–886 (2006).
  Article CAS PubMed Google Scholar
• Oelschlaeger, T. A., Dobrindt, U. & Hacker, J. Pathogenicity islands of uropathogenic E. coli and the evolution of virulence. Int. J. Antimicrob. Agents 19, 517–521 (2002).
  Article CAS PubMed Google Scholar
• Ye, C. & Xu, J. Prevalence of iron transport gene on pathogenicity-associated island of uropathogenic Escherichia coli in E. coli O157:H7 containing Shiga toxin gene. J. Clin. Microbiol. 39, 2300–2305 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Lloyd, A. L., Rasko, D. A. & Mobley, H. L. Defining genomic islands and uropathogen-specific genes in uropathogenic Escherichia coli. J. Bacteriol. 189, 3532–3546 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Flannery, E. L., Mody, L. & Mobley, H. L. Identification of a modular pathogenicity island that is widespread among urease-producing uropathogens and shares features with a diverse group of mobile elements. Infect. Immun. 77, 4887–4894 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Ochman, H., Lawrence, J. G. & Groisman, E. A. Lateral gene transfer and the nature of bacterial innovation. Nature 405, 299–304 (2000).
  Article CAS PubMed Google Scholar
• Connell, I. et al. Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract. Proc. Natl Acad. Sci. USA 93, 9827–9832 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Wu, X. R., Sun, T. T. & Medina, J. J. In vitro binding of type 1-fimbriated Escherichia coli to uroplakins Ia and Ib: relation to urinary tract infections. Proc. Natl Acad. Sci. USA 93, 9630–9635 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Lane, M. C. & Mobley, H. L. Role of P-fimbrial-mediated adherence in pyelonephritis and persistence of uropathogenic Escherichia coli (UPEC) in the mammalian kidney. Kidney Int. 72, 19–25 (2007).
  Article CAS PubMed Google Scholar
• Westerlund, B. et al. The O75X adhesin of uropathogenic Escherichia coli is a type IV collagen-binding protein. Mol. Microbiol. 3, 329–337 (1989).
  Article CAS PubMed Google Scholar
• Goluszko, P. et al. Development of experimental model of chronic pyelonephritis with Escherichia coli O75:K5:H-bearing Dr fimbriae: mutation in the dra region prevented tubulointerstitial nephritis. J. Clin. Invest. 99, 1662–1672 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Das, M. et al. Hydrophilic domain II of Escherichia coli Dr fimbriae facilitates cell invasion. Infect. Immun. 73, 6119–6126 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Pere, A., Nowicki, B., Saxen, H., Siitonen, A. & Korhonen, T. K. Expression of P, type-1, and type-1C fimbriae of Escherichia coli in the urine of patients with acute urinary tract infection. J. Infect. Dis. 156, 567–574 (1987).
  Article CAS PubMed Google Scholar
• Buckles, E. L. et al. Identification and characterization of a novel uropathogenic _Escherichia coli_-associated fimbrial gene cluster. Infect. Immun. 72, 3890–3901 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Valle, J. et al. UpaG, a new member of the trimeric autotransporter family of adhesins in uropathogenic Escherichia coli. J. Bacteriol. 190, 4147–4161 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Boehm, D. F., Welch, R. A. & Snyder, I. S. Calcium is required for binding of Escherichia coli hemolysin (HlyA) to erythrocyte membranes. Infect. Immun. 58, 1951–1958 (1990).
  CAS PubMed PubMed Central Google Scholar
• Island, M. D. et al. Cytotoxicity of hemolytic, cytotoxic necrotizing factor 1-positive and -negative Escherichia coli to human T24 bladder cells. Infect. Immun. 66, 3384–3389 (1998).
  CAS PubMed PubMed Central Google Scholar
• Mobley, H. L. et al. Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains. Infect. Immun. 58, 1281–1289 (1990).
  CAS PubMed PubMed Central Google Scholar
• Trifillis, A. L. et al. Binding to and killing of human renal epithelial cells by hemolytic P-fimbriated E. coli. Kidney Int. 46, 1083–1091 (1994).
  Article CAS PubMed Google Scholar
• Uhlen, P. et al. Alpha-haemolysin of uropathogenic E. coli induces Ca2+ oscillations in renal epithelial cells. Nature 405, 694–697 (2000).
  Article CAS PubMed Google Scholar
• Smith, Y. C., Rasmussen, S. B., Grande, K. K., Conran, R. M. & O'Brien, A. D. Hemolysin of uropathogenic Escherichia coli evokes extensive shedding of the uroepithelium and hemorrhage in bladder tissue within the first 24 hours after intraurethral inoculation of mice. Infect. Immun. 76, 2978–2990 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• O'Hanley, P., Lalonde, G. & Ji, G. Alpha-hemolysin contributes to the pathogenicity of piliated digalactoside-binding Escherichia coli in the kidney: efficacy of an alpha-hemolysin vaccine in preventing renal injury in the BALB/c mouse model of pyelonephritis. Infect. Immun. 59, 1153–1161 (1991).
  CAS PubMed PubMed Central Google Scholar
• Boquet, P. The cytotoxic necrotizing factor 1 (CNF1) from Escherichia coli. Toxicon 39, 1673–1680 (2001).
  Article CAS PubMed Google Scholar
• Lemonnier, M., Landraud, L. & Lemichez, E. Rho GTPase-activating bacterial toxins: from bacterial virulence regulation to eukaryotic cell biology. FEMS Microbiol. Rev. 31, 515–534 (2007).
  Article CAS PubMed Google Scholar
• Falzano, L. et al. Induction of phagocytic behaviour in human epithelial cells by Escherichia coli cytotoxic necrotizing factor type 1. Mol. Microbiol. 9, 1247–1254 (1993).
  Article CAS PubMed Google Scholar
• Hofman, P. et al. Escherichia coli cytotoxic necrotizing factor-1 (CNF-1) increases the adherence to epithelia and the oxidative burst of human polymorphonuclear leukocytes but decreases bacteria phagocytosis. J. Leukoc. Biol. 68, 522–528 (2000).
  CAS PubMed Google Scholar
• Mills, M., Meysick, K. C. & O'Brien, A. D. Cytotoxic necrotizing factor type 1 of uropathogenic Escherichia coli kills cultured human uroepithelial 5637 cells by an apoptotic mechanism. Infect. Immun. 68, 5869–5880 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Johnson, D. E. et al. The role of cytotoxic necrotizing factor-1 in colonization and tissue injury in a murine model of urinary tract infection. FEMS Immunol. Med. Microbiol. 28, 37–41 (2000).
  Article CAS PubMed Google Scholar
• Rippere-Lampe, K. E., O'Brien, A. D., Conran, R. & Lockman, H. A. Mutation of the gene encoding cytotoxic necrotizing factor type 1 (_cnf_1) attenuates the virulence of uropathogenic Escherichia coli. Infect. Immun. 69, 3954–3964 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Parham, N. J. et al. PicU, a second serine protease autotransporter of uropathogenic Escherichia coli. FEMS Microbiol. Lett. 230, 73–83 (2004).
  Article CAS PubMed Google Scholar
• Guyer, D. M., Radulovic, S., Jones, F. E. & Mobley, H. L. Sat, the secreted autotransporter toxin of uropathogenic Escherichia coli, is a vacuolating cytotoxin for bladder and kidney epithelial cells. Infect. Immun. 70, 4539–4546 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Heimer, S. R., Rasko, D. A., Lockatell, C. V., Johnson, D. E. & Mobley, H. L. Autotransporter genes pic and tsh are associated with Escherichia coli strains that cause acute pyelonephritis and are expressed during urinary tract infection. Infect. Immun. 72, 593–597 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Lane, M. C. et al. Role of motility in the colonization of uropathogenic Escherichia coli in the urinary tract. Infect. Immun. 73, 7644–7656 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Wright, K. J., Seed, P. C. & Hultgren, S. J. Uropathogenic Escherichia coli flagella aid in efficient urinary tract colonization. Infect. Immun. 73, 7657–7668 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Snyder, J. A. et al. Transcriptome of uropathogenic Escherichia coli during urinary tract infection. Infect. Immun. 72, 6373–6381 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Lane, M. C., Alteri, C. J., Smith, S. N. & Mobley, H. L. Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract. Proc. Natl Acad. Sci. USA 104, 16669–16674 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Hagan, E. C. & Mobley, H. L. Haem acquisition is facilitated by a novel receptor Hma and required by uropathogenic Escherichia coli for kidney infection. Mol. Microbiol. 71, 79–91 (2009).
  Article CAS PubMed Google Scholar
• Torres, A. G., Redford, P., Welch, R. A. & Payne, S. M. TonB-dependent systems of uropathogenic Escherichia coli: aerobactin and heme transport and TonB are required for virulence in the mouse. Infect. Immun. 69, 6179–6185 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Johnson, J. R. et al. The IrgA homologue adhesin Iha is an Escherichia coli virulence factor in murine urinary tract infection. Infect. Immun. 73, 965–971 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Russo, T. A., Carlino, U. B. & Johnson, J. R. Identification of a new iron-regulated virulence gene, ireA, in an extraintestinal pathogenic isolate of Escherichia coli. Infect. Immun. 69, 6209–6216 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Russo, T. A. et al. Iron functions as a siderophore receptor and is a urovirulence factor in an extraintestinal pathogenic isolate of Escherichia coli. Infect. Immun. 70, 7156–7160 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Sabri, M., Houle, S. & Dozois, C. M. Roles of the extraintestinal pathogenic Escherichia coli ZnuACB and ZupT zinc transporters during urinary tract infection. Infect. Immun. 77, 1155–1164 (2009).
  Article CAS PubMed Google Scholar
• Goetz, D. H. et al. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol. Cell 10, 1033–1043 (2002).
  Article CAS PubMed Google Scholar
• Fischbach, M. A. et al. The pathogen-associated iroA gene cluster mediates bacterial evasion of lipocalin 2. Proc. Natl Acad. Sci. USA 103, 16502–16507 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Smith, K. D. Iron metabolism at the host pathogen interface: lipocalin 2 and the pathogen-associated iroA gene cluster. Int. J. Biochem. Cell. Biol. 39, 1776–1780 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Cirl, C. et al. Subversion of Toll-like receptor signaling by a unique family of bacterial Toll/interleukin-1 receptor domain-containing proteins. Nat. Med. 14, 399–406 (2008).
  Article CAS PubMed Google Scholar
• Billips, B. K., Schaeffer, A. J. & Klumpp, D. J. Molecular basis of uropathogenic Escherichia coli evasion of the innate immune response in the bladder. Infect. Immun. 76, 3891–3900 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Hunstad, D. A., Justice, S. S., Hung, C. S., Lauer, S. R. & Hultgren, S. J. Suppression of bladder epithelial cytokine responses by uropathogenic Escherichia coli. Infect. Immun. 73, 3999–4006 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Johnson, J. R., Clabots, C. & Rosen, H. Effect of inactivation of the global oxidative stress regulator oxyR on the colonization ability of Escherichia coli O1:K1:H7 in a mouse model of ascending urinary tract infection. Infect. Immun. 74, 461–468 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Bower, J. M. & Mulvey, M. A. Polyamine-mediated resistance of uropathogenic Escherichia coli to nitrosative stress. J. Bacteriol. 188, 928–933 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Kulesus, R. R., Diaz-Perez, K., Slechta, E. S., Eto, D. S. & Mulvey, M. A. Impact of the RNA chaperone Hfq on the fitness and virulence potential of uropathogenic Escherichia coli. Infect. Immun. 76, 3019–3026 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Svensson, L., Marklund, B. I., Poljakovic, M. & Persson, K. Uropathogenic Escherichia coli and tolerance to nitric oxide: the role of flavohemoglobin. J. Urol. 175, 749–753 (2006).
  Article CAS PubMed Google Scholar
• Lloyd, A. L., Smith, S. N., Eaton, K. A. & Mobley, H. L. Uropathogenic Escherichia coli suppresses the host inflammatory response via pathogenicity island genes sisA and sisB. Infect. Immun. 77, 5322–5333 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Li, K., Feito, M. J., Sacks, S. H. & Sheerin, N. S. CD46 (membrane cofactor protein) acts as a human epithelial cell receptor for internalization of opsonized uropathogenic Escherichia coli. J. Immunol. 177, 2543–2551 (2006).
  Article CAS PubMed Google Scholar
• Mysorekar, I. U. & Hultgren, S. J. Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract. Proc. Natl Acad. Sci. USA 103, 14170–14175 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Anderson, G. G. et al. Intracellular bacterial biofilm-like pods in urinary tract infections. Science 301, 105–107 (2003).
  Article CAS PubMed Google Scholar
• Rosen, D. A., Hooton, T. M., Stamm, W. E., Humphrey, P. A. & Hultgren, S. J. Detection of intracellular bacterial communities in human urinary tract infection. PLoS Med. 4, e329 (2007).
  Article PubMed PubMed Central Google Scholar
• Anderson, G. G., Martin, S. M. & Hultgren, S. J. Host subversion by formation of intracellular bacterial communities in the urinary tract. Microbes Infect. 6, 1094–1101 (2004).
  Article PubMed Google Scholar
• Justice, S. S. et al. Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis. Proc. Natl Acad. Sci. USA 101, 1333–1338 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Rocha, S. P., Pelayo, J. S. & Elias, W. P. Fimbriae of uropathogenic Proteus mirabilis. FEMS Immunol. Med. Microbiol. 51, 1–7 (2007).
  Article CAS PubMed Google Scholar
• Bahrani, F. K., Johnson, D. E., Robbins, D. & Mobley, H. L. Proteus mirabilis flagella and MR/P fimbriae: isolation, purification, N-terminal analysis, and serum antibody response following experimental urinary tract infection. Infect. Immun. 59, 3574–3580 (1991).
  CAS PubMed PubMed Central Google Scholar
• Jansen, A. M., Lockatell, V., Johnson, D. E. & Mobley, H. L. Mannose-resistant _Proteus_-like fimbriae are produced by most Proteus mirabilis strains infecting the urinary tract, dictate the in vivo localization of bacteria, and contribute to biofilm formation. Infect. Immun. 72, 7294–7305 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Li, X., Johnson, D. E. & Mobley, H. L. Requirement of MrpH for mannose-resistant _Proteus_-like fimbria-mediated hemagglutination by Proteus mirabilis. Infect. Immun. 67, 2822–2833 (1999).
  CAS PubMed PubMed Central Google Scholar
• Bahrani, F. K. et al. Construction of an MR/P fimbrial mutant of Proteus mirabilis: role in virulence in a mouse model of ascending urinary tract infection. Infect. Immun. 62, 3363–3371 (1994).
  CAS PubMed PubMed Central Google Scholar
• Li, X., Lockatell, C. V., Johnson, D. E. & Mobley, H. L. Identification of MrpI as the sole recombinase that regulates the phase variation of MR/P fimbria, a bladder colonization factor of uropathogenic Proteus mirabilis. Mol. Microbiol. 45, 865–874 (2002).
  Article CAS PubMed Google Scholar
• Altman, E. et al. Galectin-3-mediated adherence of Proteus mirabilis to Madin-Darby canine kidney cells. Biochem. Cell. Biol. 79, 783–788 (2001).
  Article CAS PubMed Google Scholar
• Lee, K. K., Harrison, B. A., Latta, R. & Altman, E. The binding of Proteus mirabilis nonagglutinating fimbriae to ganglio-series asialoglycolipids and lactosyl ceramide. Can. J. Microbiol. 46, 961–966 (2000).
  Article CAS PubMed Google Scholar
• Wray, S. K., Hull, S. I., Cook, R. G., Barrish, J. & Hull, R. A. Identification and characterization of a uroepithelial cell adhesin from a uropathogenic isolate of Proteus mirabilis. Infect. Immun. 54, 43–49 (1986).
  CAS PubMed PubMed Central Google Scholar
• Massad, G., Lockatell, C. V., Johnson, D. E. & Mobley, H. L. Proteus mirabilis fimbriae: construction of an isogenic pmfA mutant and analysis of virulence in a CBA mouse model of ascending urinary tract infection. Infect. Immun. 62, 536–542 (1994).
  CAS PubMed PubMed Central Google Scholar
• Zunino, P. et al. Proteus mirabilis fimbriae (PMF) are important for both bladder and kidney colonization in mice. Microbiology 149, 3231–3237 (2003).
  Article CAS PubMed Google Scholar
• Massad, G., Bahrani, F. K. & Mobley, H. L. Proteus mirabilis fimbriae: identification, isolation, and characterization of a new ambient-temperature fimbria. Infect. Immun. 62, 1989–1994 (1994).
  CAS PubMed PubMed Central Google Scholar
• Zunino, P., Geymonat, L., Allen, A. G., Legnani-Fajardo, C. & Maskell, D. J. Virulence of a Proteus mirabilis ATF isogenic mutant is not impaired in a mouse model of ascending urinary tract infection. FEMS Immunol. Med. Microbiol. 29, 137–143 (2000).
  Article CAS PubMed Google Scholar
• Bijlsma, I. G., van Dijk, L., Kusters, J. G. & Gaastra, W. Nucleotide sequences of two fimbrial major subunit genes, pmpA and ucaA, from canine-uropathogenic Proteus mirabilis strains. Microbiology 141, 1349–1357 (1995).
  Article CAS PubMed Google Scholar
• Uphoff, T. S. & Welch, R. A. Nucleotide sequencing of the Proteus mirabilis calcium-independent hemolysin genes (hpmA and hpmB) reveals sequence similarity with the Serratia marcescens hemolysin genes (shlA and shlB). J. Bacteriol. 172, 1206–1216 (1990).
  Article CAS PubMed PubMed Central Google Scholar
• Welch, R. A. Identification of two different hemolysin determinants in uropathogenic Proteus isolates. Infect. Immun. 55, 2183–2190 (1987).
  CAS PubMed PubMed Central Google Scholar
• Alamuri, P. & Mobley, H. L. A novel autotransporter of uropathogenic Proteus mirabilis is both a cytotoxin and an agglutinin. Mol. Microbiol. 68, 997–1017 (2008).
  Article CAS PubMed Google Scholar
• Alamuri, P., Eaton, K. A., Himpsl, S. D., Smith, S. N. & Mobley, H. L. Vaccination with proteus toxic agglutinin, a hemolysin-independent cytotoxin in vivo, protects against Proteus mirabilis urinary tract infection. Infect. Immun. 77, 632–641 (2009).
  Article CAS PubMed Google Scholar
• Rather, P. N. Swarmer cell differentiation in Proteus mirabilis. Environ. Microbiol. 7, 1065–1073 (2005).
  Article CAS PubMed Google Scholar
• Jansen, A. M., Lockatell, C. V., Johnson, D. E. & Mobley, H. L. Visualization of Proteus mirabilis morphotypes in the urinary tract: the elongated swarmer cell is rarely observed in ascending urinary tract infection. Infect. Immun. 71, 3607–3613 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Jones, B. V., Young, R., Mahenthiralingam, E. & Stickler, D. J. Ultrastructure of Proteus mirabilis swarmer cell rafts and role of swarming in catheter-associated urinary tract infection. Infect. Immun. 72, 3941–3950 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Mobley, H. L. et al. Construction of a flagellum-negative mutant of Proteus mirabilis: effect on internalization by human renal epithelial cells and virulence in a mouse model of ascending urinary tract infection. Infect. Immun. 64, 5332–5340 (1996).
  CAS PubMed PubMed Central Google Scholar
• Zunino, P., Piccini, C. & Legnani-Fajardo, C. Flagellate and non-flagellate Proteus mirabilis in the development of experimental urinary tract infection. Microb. Pathog. 16, 379–385 (1994).
  Article CAS PubMed Google Scholar
• Evanylo, L. P., Kadis, S. & Maudsley, J. R. Siderophore production by Proteus mirabilis. Can. J. Microbiol. 30, 1046–1051 (1984).
  Article CAS PubMed Google Scholar
• Lima, A., Zunino, P., D'Alessandro, B. & Piccini, C. An iron-regulated outer-membrane protein of Proteus mirabilis is a haem receptor that plays an important role in urinary tract infection and in in vivo growth. J. Med. Microbiol. 56, 1600–1607 (2007).
  Article CAS PubMed Google Scholar
• Drechsel, H., Thieken, A., Reissbrodt, R., Jung, G. & Winkelmann, G. Alpha-keto acids are novel siderophores in the genera Proteus, Providencia, and Morganella and are produced by amino acid deaminases. J. Bacteriol. 175, 2727–2733 (1993).
  Article CAS PubMed PubMed Central Google Scholar
• Massad, G., Zhao, H. & Mobley, H. L. Proteus mirabilis amino acid deaminase: cloning, nucleotide sequence, and characterization of aad. J. Bacteriol. 177, 5878–5883 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Nielubowicz, G. R., Smith, S. N. & Mobley, H. L. Zinc uptake contributes to motility and provides a competitive advantage to Proteus mirabilis during experimental urinary tract infection. Infect. Immun. 78, 2823–2833 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Belas, R., Manos, J. & Suvanasuthi, R. Proteus mirabilis ZapA metalloprotease degrades a broad spectrum of substrates, including antimicrobial peptides. Infect. Immun. 72, 5159–5167 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Senior, B. W., Loomes, L. M. & Kerr, M. A. The production and activity in vivo of Proteus mirabilis IgA protease in infections of the urinary tract. J. Med. Microbiol. 35, 203–207 (1991).
  Article CAS PubMed Google Scholar
• Walker, K. E., Moghaddame-Jafari, S., Lockatell, C. V., Johnson, D. & Belas, R. ZapA, the IgA-degrading metalloprotease of Proteus mirabilis, is a virulence factor expressed specifically in swarmer cells. Mol. Microbiol. 32, 825–836 (1999).
  Article CAS PubMed Google Scholar
• Belas, R. & Flaherty, D. Sequence and genetic analysis of multiple flagellin-encoding genes from Proteus mirabilis. Gene 148, 33–41 (1994).
  Article CAS PubMed Google Scholar
• Belas, R. Expression of multiple flagellin-encoding genes of Proteus mirabilis. J. Bacteriol. 176, 7169–7181 (1994).
  Article CAS PubMed PubMed Central Google Scholar
• Murphy, C. A. & Belas, R. Genomic rearrangements in the flagellin genes of Proteus mirabilis. Mol. Microbiol. 31, 679–690 (1999).
  Article CAS PubMed Google Scholar
• Zhao, H., Li, X., Johnson, D. E., Blomfield, I. & Mobley, H. L. In vivo phase variation of MR/P fimbrial gene expression in Proteus mirabilis infecting the urinary tract. Mol. Microbiol. 23, 1009–1019 (1997).
  Article CAS PubMed Google Scholar
• Li, X. et al. Visualization of Proteus mirabilis within the matrix of urease-induced bladder stones during experimental urinary tract infection. Infect. Immun. 70, 389–394 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Thomas, W. E., Nilsson, L. M., Forero, M., Sokurenko, E. V. & Vogel, V. Shear-dependent 'stick-and-roll' adhesion of type 1 fimbriated Escherichia coli. Mol. Microbiol. 53, 1545–1557 (2004).
  Article CAS PubMed Google Scholar
• Wu, X. R., Kong, X. P., Pellicer, A., Kreibich, G. & Sun, T. T. Uroplakins in urothelial biology, function, and disease. Kidney Int. 75, 1153–1165 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Zhou, G. et al. Uroplakin Ia is the urothelial receptor for uropathogenic Escherichia coli: evidence from in vitro FimH binding. J. Cell. Sci. 114, 4095–4103 (2001).
  CAS PubMed Google Scholar
• Mulvey, M. A. et al. Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science 282, 1494–1497 (1998).
  Article CAS PubMed Google Scholar
• Fukushi, Y., Orikasa, S. & Kagayama, M. An electron microscopic study of the interaction between vesical epitherlium and E. coli. Invest. Urol. 17, 61–68 (1979).
  CAS PubMed Google Scholar
• Klumpp, D. J. et al. Uropathogenic Escherichia coli potentiates type 1 pilus-induced apoptosis by suppressing NF-κB. Infect. Immun. 69, 6689–6695 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Sivick, K. E. & Mobley, H. L. Waging war against uropathogenic Escherichia coli: winning back the urinary tract. Infect. Immun. 78, 568–585 (2010).
  Article CAS PubMed Google Scholar
• Wullt, B. et al. The host response to urinary tract infection. Infect. Dis. Clin. North Am. 17, 279–301 (2003).
  Article PubMed Google Scholar
• Chromek, M. et al. The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat. Med. 12, 636–641 (2006).
  Article CAS PubMed Google Scholar
• Morrison, G., Kilanowski, F., Davidson, D. & Dorin, J. Characterization of the mouse beta defensin 1, Defb1, mutant mouse model. Infect. Immun. 70, 3053–3060 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Valore, E. V. et al. Human beta-defensin-1: an antimicrobial peptide of urogenital tissues. J. Clin. Invest. 101, 1633–1642 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Ganz, T. Iron in innate immunity: starve the invaders. Curr. Opin. Immunol. 21, 63–67 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Serafini-Cessi, F., Malagolini, N. & Cavallone, D. Tamm-Horsfall glycoprotein: biology and clinical relevance. Am. J. Kidney Dis. 42, 658–676 (2003).
  Article CAS PubMed Google Scholar
• Raffi, H. S., Bates, J. M., Jr, Laszik, Z. & Kumar, S. Tamm-horsfall protein protects against urinary tract infection by Proteus mirabilis. J. Urol. 181, 2332–2338 (2009).
  Article PubMed PubMed Central Google Scholar
• Ingersoll, M. A., Kline, K. A., Nielsen, H. V. & Hultgren, S. J. G-CSF induction early in uropathogenic Escherichia coli infection of the urinary tract modulates host immunity. Cell. Microbiol. 10, 2568–2578 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Sivick, K. E., Schaller, M. A., Smith, S. N. & Mobley, H. L. The innate immune response to uropathogenic Escherichia coli involves IL-17A in a murine model of urinary tract infection. J. Immunol. 184, 2065–2075 (2010).
  Article CAS PubMed Google Scholar
• Hedges, S. et al. Uroepithelial cells are part of a mucosal cytokine network. Infect. Immun. 62, 2315–2321 (1994).
  CAS PubMed PubMed Central Google Scholar
• Schilling, J. D., Mulvey, M. A., Vincent, C. D., Lorenz, R. G. & Hultgren, S. J. Bacterial invasion augments epithelial cytokine responses to Escherichia coli through a lipopolysaccharide-dependent mechanism. J. Immunol. 166, 1148–1155 (2001).
  Article CAS PubMed Google Scholar
• Wullt, B. et al. P-fimbriae trigger mucosal responses to Escherichia coli in the human urinary tract. Cell. Microbiol. 3, 255–264 (2001).
  Article CAS PubMed Google Scholar
• Agace, W. W. The role of the epithelial cell in Escherichia coli induced neutrophil migration into the urinary tract. Eur. Respir. J. 9, 1713–1728 (1996).
  Article CAS PubMed Google Scholar
• Agace, W. W., Hedges, S. R., Ceska, M. & Svanborg, C. Interleukin-8 and the neutrophil response to mucosal gram-negative infection. J. Clin. Invest. 92, 780–785 (1993).
  Article CAS PubMed PubMed Central Google Scholar
• Hang, L. et al. Macrophage inflammatory protein-2 is required for neutrophil passage across the epithelial barrier of the infected urinary tract. J. Immunol. 162, 3037–3044 (1999).
  CAS PubMed Google Scholar
• Haraoka, M. et al. Neutrophil recruitment and resistance to urinary tract infection. J. Infect. Dis. 180, 1220–1229 (1999).
  Article CAS PubMed Google Scholar
• Ragnarsdottir, B. et al. TLR- and CXCR1-dependent innate immunity: insights into the genetics of urinary tract infections. Eur. J. Clin. Invest. 38 (Suppl. 2), 12–20 (2008).
  Article CAS PubMed Google Scholar
• Ashkar, A. A., Mossman, K. L., Coombes, B. K., Gyles, C. L. & Mackenzie, R. FimH adhesin of type 1 fimbriae is a potent inducer of innate antimicrobial responses which requires TLR4 and type 1 interferon signalling. PLoS Pathog. 4, e1000233 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Schilling, J. D., Martin, S. M., Hung, C. S., Lorenz, R. G. & Hultgren, S. J. Toll-like receptor 4 on stromal and hematopoietic cells mediates innate resistance to uropathogenic Escherichia coli. Proc. Natl Acad. Sci. USA 100, 4203–4208 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Patole, P. S. et al. Toll-like receptor-4: renal cells and bone marrow cells signal for neutrophil recruitment during pyelonephritis. Kidney Int. 68, 2582–2587 (2005).
  Article CAS PubMed Google Scholar
• Frendeus, B. et al. Escherichia coli P fimbriae utilize the Toll-like receptor 4 pathway for cell activation. Mol. Microbiol. 40, 37–51 (2001).
  Article CAS PubMed Google Scholar
• Hedges, S., Svensson, M. & Svanborg, C. Interleukin-6 response of epithelial cell lines to bacterial stimulation in vitro. Infect. Immun. 60, 1295–1301 (1992).
  CAS PubMed PubMed Central Google Scholar
• Hedlund, M. et al. P fimbriae-dependent, lipopolysaccharide-independent activation of epithelial cytokine responses. Mol. Microbiol. 33, 693–703 (1999).
  Article CAS PubMed Google Scholar
• Hedlund, M. et al. Type 1 fimbriae deliver an LPS- and TLR4-dependent activation signal to CD14-negative cells. Mol. Microbiol. 39, 542–552 (2001).
  Article CAS PubMed Google Scholar
• Mossman, K. L. et al. Cutting edge: FimH adhesin of type 1 fimbriae is a novel TLR4 ligand. J. Immunol. 181, 6702–6706 (2008).
  Article CAS PubMed Google Scholar
• Fischer, H., Yamamoto, M., Akira, S., Beutler, B. & Svanborg, C. Mechanism of pathogen-specific TLR4 activation in the mucosa: fimbriae, recognition receptors and adaptor protein selection. Eur. J. Immunol. 36, 267–277 (2006).
  Article CAS PubMed Google Scholar
• Andersen-Nissen, E. et al. Cutting edge: Tlr5−/− mice are more susceptible to Escherichia coli urinary tract infection. J. Immunol. 178, 4717–4720 (2007).
  Article CAS PubMed Google Scholar
• Hayashi, F. et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410, 1099–1103 (2001).
  Article CAS PubMed Google Scholar
• Zhang, D. et al. A toll-like receptor that prevents infection by uropathogenic bacteria. Science 303, 1522–1526 (2004).
  Article CAS PubMed Google Scholar
• Thumbikat, P., Waltenbaugh, C., Schaeffer, A. J. & Klumpp, D. J. Antigen-specific responses accelerate bacterial clearance in the bladder. J. Immunol. 176, 3080–3086 (2006).
  Article CAS PubMed Google Scholar
• Pearsall, N. N. & Sherris, J. C. The demonstration of specific urinary anti-bodies in urinary tract infections caused by Gram-negative bacilli. J. Pathol. Bacteriol. 91, 589–595 (1966).
  Article CAS PubMed Google Scholar
• Eden, C. S., Hanson, L. A., Jodal, U., Lindberg, U. & Akerlund, A. S. Variable adherence to normal human urinary-tract epithelial cells of Escherichia coli strains associated with various forms of urinary-tract infection. Lancet 1, 490–492 (1976).
  Article CAS PubMed Google Scholar
• Svanborg-Eden, C. & Svennerholm, A. M. Secretory immunoglobulin A and G antibodies prevent adhesion of Escherichia coli to human urinary tract epithelial cells. Infect. Immun. 22, 790–797 (1978).
  CAS PubMed PubMed Central Google Scholar
• Trinchieri, A. et al. Secretory immunoglobulin A and inhibitory activity of bacterial adherence to epithelial cells in urine from patients with urinary tract infections. Urol. Res. 18, 305–308 (1990).
  Article CAS PubMed Google Scholar
• Svanborg, C. et al. Uropathogenic Escherichia coli as a model of host-parasite interaction. Curr. Opin. Microbiol. 9, 33–39 (2006).
  Article CAS PubMed Google Scholar
• Lomberg, H., Jodal, U., Eden, C. S., Leffler, H. & Samuelsson, B. P1 blood group and urinary tract infection. Lancet 1, 551–552 (1981).
  Article CAS PubMed Google Scholar
• Hagberg, L. et al. Difference in susceptibility to gram-negative urinary tract infection between C3H/HeJ and C3H/HeN mice. Infect. Immun. 46, 839–844 (1984).
  CAS PubMed PubMed Central Google Scholar
• Goluszko, P. et al. Vaccination with purified Dr Fimbriae reduces mortality associated with chronic urinary tract infection due to Escherichia coli bearing Dr adhesin. Infect. Immun. 73, 627–631 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Ragnarsdottir, B. et al. Reduced toll-like receptor 4 expression in children with asymptomatic bacteriuria. J. Infect. Dis. 196, 475–484 (2007).
  Article CAS PubMed Google Scholar
• Frendeus, B. et al. Interleukin 8 receptor deficiency confers susceptibility to acute experimental pyelonephritis and may have a human counterpart. J. Exp. Med. 192, 881–890 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Godaly, G., Hang, L., Frendeus, B. & Svanborg, C. Transepithelial neutrophil migration is CXCR1 dependent in vitro and is defective in IL-8 receptor knockout mice. J. Immunol. 165, 5287–5294 (2000).
  Article CAS PubMed Google Scholar
• Hang, L., Frendeus, B., Godaly, G. & Svanborg, C. Interleukin-8 receptor knockout mice have subepithelial neutrophil entrapment and renal scarring following acute pyelonephritis. J. Infect. Dis. 182, 1738–1748 (2000).
  Article CAS PubMed Google Scholar
• Lundstedt, A. C. et al. A genetic basis of susceptibility to acute pyelonephritis. PLoS ONE 2, e825 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Lundstedt, A. C. et al. Inherited susceptibility to acute pyelonephritis: a family study of urinary tract infection. J. Infect. Dis. 195, 1227–1234 (2007).
  Article PubMed Google Scholar
• Johnson, J. R. in Urinary Tract Infections: Molecular Pathogenesis and Clinical Management (eds Mobley, H. L. T. & Warren, J. W.) 95–118 (ASM Press, Washington, DC, 1996).
  Google Scholar
• Svensson, M. et al. Glycolipid depletion in antimicrobial therapy. Mol. Microbiol. 47, 453–461 (2003).
  Article CAS PubMed Google Scholar
• Bishop, B. L. et al. Cyclic AMP-regulated exocytosis of Escherichia coli from infected bladder epithelial cells. Nat. Med. 13, 625–630 (2007).
  Article CAS PubMed Google Scholar
• Bouckaert, J. et al. Receptor binding studies disclose a novel class of high-affinity inhibitors of the Escherichia coli FimH adhesin. Mol. Microbiol. 55, 441–455 (2005).
  Article CAS PubMed Google Scholar
• Thankavel, K. et al. Localization of a domain in the FimH adhesin of Escherichia coli type 1 fimbriae capable of receptor recognition and use of a domain-specific antibody to confer protection against experimental urinary tract infection. J. Clin. Invest. 100, 1123–1136 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Lilly, J. D. & Parsons, C. L. Bladder surface glycosaminoglycans is a human epithelial permeability barrier. Surg. Gynecol. Obstet. 171, 493–496 (1990).
  CAS PubMed Google Scholar
• Maki, D. G. & Tambyah, P. A. Engineering out the risk for infection with urinary catheters. Emerg. Infect. Dis. 7, 342–347 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Munasinghe, R. L., Yazdani, H., Siddique, M. & Hafeez, W. Appropriateness of use of indwelling urinary catheters in patients admitted to the medical service. Infect. Control Hosp. Epidemiol. 22, 647–649 (2001).
  Article CAS PubMed Google Scholar
• Stickler, D. J., Jones, G. L. & Russell, A. D. Control of encrustation and blockage of Foley catheters. Lancet 361, 1435–1437 (2003).
  Article CAS PubMed Google Scholar
• Hull, R. et al. Urinary tract infection prophylaxis using Escherichia coli 83972 in spinal cord injured patients. J. Urol. 163, 872–877 (2000).
  Article CAS PubMed Google Scholar
• Sabbuba, N. A. et al. Genotyping demonstrates that the strains of Proteus mirabilis from bladder stones and catheter encrustations of patients undergoing long-term bladder catheterization are identical. J. Urol. 171, 1925–1928 (2004).
  Article CAS PubMed Google Scholar
• Bauer, H. W. et al. A long-term, multicenter, double-blind study of an Escherichia coli extract (OM-89) in female patients with recurrent urinary tract infections. Eur. Urol. 47, 542–548 (2005).
  Article PubMed Google Scholar
• Hopkins, W. J., Elkahwaji, J., Beierle, L. M., Leverson, G. E. & Uehling, D. T. Vaginal mucosal vaccine for recurrent urinary tract infections in women: results of a phase 2 clinical trial. J. Urol. 177, 1349–1353 (2007).
  Article PubMed Google Scholar
• Sivick, K. E. & Mobley, H. L. An “omics” approach to uropathogenic Escherichia coli vaccinology. Trends Microbiol. 17, 431–432 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Alteri, C. J., Hagan, E. C., Sivick, K. E., Smith, S. N. & Mobley, H. L. Mucosal immunization with iron receptor antigens protects against urinary tract infection. PLoS Pathog. 5, e1000586 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Johnson, D. E. et al. Serum immunoglobulin response and protection from homologous challenge by Proteus mirabilis in a mouse model of ascending urinary tract infection. Infect. Immun. 67, 6683–6687 (1999).
  CAS PubMed PubMed Central Google Scholar
• Li, X. & Mobley, H. L. Vaccines for Proteus mirabilis in urinary tract infection. Int. J. Antimicrob. Agents 19, 461–465 (2002).
  Article CAS PubMed Google Scholar
• Moayeri, N., Collins, C. M. & O'Hanley, P. Efficacy of a Proteus mirabilis outer membrane protein vaccine in preventing experimental Proteus pyelonephritis in a BALB/c mouse model. Infect. Immun. 59, 3778–3786 (1991).
  CAS PubMed PubMed Central Google Scholar
• Scavone, P. et al. Intranasal immunisation with recombinant Lactococcus lactis displaying either anchored or secreted forms of Proteus mirabilis MrpA fimbrial protein confers specific immune response and induces a significant reduction of kidney bacterial colonisation in mice. Microbes Infect. 9, 821–828 (2007).
  Article CAS PubMed Google Scholar
• Pellegrino, R., Galvalisi, U., Scavone, P., Sosa, V. & Zunino, P. Evaluation of Proteus mirabilis structural fimbrial proteins as antigens against urinary tract infections. FEMS Immunol. Med. Microbiol. 36, 103–110 (2003).
  Article CAS PubMed Google Scholar
• Li, X. et al. Use of translational fusion of the MrpH fimbrial adhesin-binding domain with the cholera toxin A2 domain, coexpressed with the cholera toxin B subunit, as an intranasal vaccine to prevent experimental urinary tract infection by Proteus mirabilis. Infect. Immun. 72, 7306–7310 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Nielubowicz, G. R., Smith, S. N. & Mobley, H. L. Outer membrane antigens of the uropathogen Proteus mirabilis recognized by the humoral response during experimental murine urinary tract infection. Infect. Immun. 76, 4222–4231 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Serruto, D., Serino, L., Masignani, V. & Pizza, M. Genome-based approaches to develop vaccines against bacterial pathogens. Vaccine 27, 3245–3250 (2009).
  Article CAS PubMed Google Scholar
• Abraham, J. M., Freitag, C. S., Clements, J. R. & Eisenstein, B. I. An invertible element of DNA controls phase variation of type 1 fimbriae of Escherichia coli. Proc. Natl Acad. Sci. USA 82, 5724–5727 (1985).
  Article CAS PubMed PubMed Central Google Scholar
• Klemm, P. Two regulatory fim genes, fimB and fimE, control the phase variation of type 1 fimbriae in Escherichia coli. EMBO J. 5, 1389–1393 (1986).
  Article CAS PubMed PubMed Central Google Scholar
• Bryan, A. et al. Regulation of type 1 fimbriae by unlinked FimB- and FimE-like recombinases in uropathogenic Escherichia coli strain CFT073. Infect. Immun. 74, 1072–1083 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Lane, M. C., Li, X., Pearson, M. M., Simms, A. N. & Mobley, H. L. Oxygen-limiting conditions enrich for fimbriate cells of uropathogenic Proteus mirabilis and Escherichia coli. J. Bacteriol. 191, 1382–1392 (2009).
  Article CAS PubMed Google Scholar
• Li, X., Rasko, D. A., Lockatell, C. V., Johnson, D. E. & Mobley, H. L. Repression of bacterial motility by a novel fimbrial gene product. EMBO J. 20, 4854–4862 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Pearson, M. M. & Mobley, H. L. Repression of motility during fimbrial expression: identification of 14 mrpJ gene paralogues in Proteus mirabilis. Mol. Microbiol. 69, 548–558 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Simms, A. N. & Mobley, H. L. PapX, a P fimbrial operon-encoded inhibitor of motility in uropathogenic Escherichia coli. Infect. Immun. 76, 4833–4841 (2008).
  Article CAS PubMed PubMed Central Google Scholar